ID   EEC16-TERT-R
AC   CVCL_YZ63
SY   EEC16-TERT-Retroviral
DR   Wikidata; Q98125947
RX   PubMed=24972189;
CC   Doubling time: 30.7 +- 4.1 days (PubMed=24972189).
CC   Genetic integration: Method=Transduction; Gene=HGNC; HGNC:11730; TERT.
CC   Genetic integration: Method=Transduction; Gene=UniProtKB; P00557; Escherichia coli hygromycin-B 4-O-kinase (hph) (HygR).
CC   Derived from site: In situ; Endometrium; UBERON=UBERON_0001295.
ST   Source(s): PubMed=24972189
ST   Amelogenin: X
ST   CSF1PO: 10
ST   D13S317: 10,11
ST   D16S539: 12,13
ST   D18S51: 17,20
ST   D21S11: 29,31.2
ST   D3S1358: 14,16
ST   D5S818: 11,12
ST   D7S820: 9,10
ST   D8S1179: 13,14
ST   FGA: 21,22
ST   Penta D: 10,11
ST   Penta E: 10,13
ST   TH01: 7,9.3
ST   TPOX: 8
ST   vWA: 14
DI   NCIt; C3014; Endometriosis
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_YZ61 ! EEC16
SX   Female
AG   34Y
CA   Telomerase immortalized cell line
DT   Created: 02-07-20; Last updated: 19-12-24; Version: 10
//
RX   PubMed=24972189; DOI=10.1016/j.ygyno.2014.06.016;
RA   Lawrenson K., Lee N., Torres H.A.M., Lee J.M., Brueggmann D., Rao P.N.,
RA   Noushmehr H., Gayther S.A.;
RT   "Src as a novel therapeutic target for endometriosis.";
RL   Gynecol. Oncol. 135:100-107(2014).
//